{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:27:39Z","timestamp":1759530459697,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/jpet.112.202796","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T07:02:12Z","timestamp":1360306932000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Monocarboxylate Transporter Inhibition on the Oral Toxicokinetics\/Toxicodynamics of \u03b3-Hydroxybutyrate and \u03b3-Butyrolactone"],"prefix":"10.1016","volume":"345","author":[{"given":"Bridget L.","family":"Morse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.202796_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.annemergmed.2005.10.012","article-title":"Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003","volume":"47","author":"Anderson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.112.202796_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.104.069682","article-title":"GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier","volume":"311","author":"Bhattacharya","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202796_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jat\/28.8.625","article-title":"Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects","volume":"28","author":"Brenneisen","year":"2004","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.112.202796_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.202796_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.annemergmed.2004.12.013","article-title":"Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice","volume":"45","author":"Carai","year":"2005","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.112.202796_bib29","unstructured":"Center for Behavioral Health Statistics and Quality (2011) Drug Abuse Warning Network, 2008: national estimates of drug-related emergency department visits. HHS Publication No. SMA 11-4618. Rockville, MD: Substance Abuse and Mental Health Services Administration."},{"key":"10.1124\/jpet.112.202796_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/bmc.1370","article-title":"Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration","volume":"24","author":"Chen","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/jpet.112.202796_bib7","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1124\/dmd.109.027169","article-title":"The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition","volume":"37","author":"Cui","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202796_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1208\/s12248-010-9197-x","article-title":"Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy","volume":"12","author":"Felmlee","year":"2010","journal-title":"AAPS J"},{"key":"10.1124\/jpet.112.202796_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","article-title":"Sodium-coupled monocarboxylate transporters in normal tissues and in cancer","volume":"10","author":"Ganapathy","year":"2008","journal-title":"AAPS J"},{"key":"10.1124\/jpet.112.202796_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.145.3632.583","article-title":"Differential estimation of gamma-butyrolactone and gamma-hydroxybutyric acid in rat blood and brain","volume":"145","author":"Giarman","year":"1964","journal-title":"Science"},{"key":"10.1124\/jpet.112.202796_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-009-1477-8","article-title":"Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons","volume":"204","author":"Goodwin","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.202796_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF00965839","article-title":"An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway","volume":"16","author":"Kaufman","year":"1991","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.112.202796_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jat\/29.6.582","article-title":"Unusually high concentrations in a fatal GHB case","volume":"29","author":"Kintz","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.112.202796_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1113\/expphysiol.2009.046797","article-title":"Dietary pectin up-regulates monocaboxylate transporter 1 in the rat gastrointestinal tract","volume":"94","author":"Kirat","year":"2009","journal-title":"Exp Physiol"},{"key":"10.1124\/jpet.112.202796_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00414-008-0299-2","article-title":"Forensic toxicology findings in deaths involving gamma-hydroxybutyrate","volume":"124","author":"Kugelberg","year":"2010","journal-title":"Int J Legal Med"},{"key":"10.1124\/jpet.112.202796_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/dmd.109.030775","article-title":"Monocarboxylate transporter-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells","volume":"38","author":"Lam","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202796_bib17","first-page":"425","article-title":"Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid","volume":"13","author":"Lettieri","year":"1976","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1124\/jpet.112.202796_bib18","first-page":"107","article-title":"Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone","volume":"22","author":"Lettieri","year":"1978","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1124\/jpet.112.202796_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)31515-6","article-title":"Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat","volume":"208","author":"Lettieri","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202796_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jat\/29.5.398","article-title":"Distribution of GHB in tissues and fluids following a fatal overdose","volume":"29","author":"Mazarr-Proo","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.112.202796_bib21","first-page":"243","article-title":"Monocarboxylate transporters: past, present, and future","volume":"24","author":"Merezhinskaya","year":"2009","journal-title":"Histol Histopathol"},{"key":"10.1124\/jpet.112.202796_bib22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/jpet.105.083253","article-title":"Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy","volume":"313","author":"Morris","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202796_bib23","doi-asserted-by":"crossref","unstructured":"Morris ME, Morse BL, Baciewicz GJ, Tessena MM, Acquisto NM, Hutchinson DJ, DiCenzo R (2011) Monocarboxylate transporter inhibition with osmotic diuresis increases \u03b3-hydroxybutyrate renal elimination in humans: a proof-of-concept study. J Clinic Toxicol 1:105 DOI:10.4172\/2161-0495.1000105.","DOI":"10.4172\/2161-0495.1000105"},{"key":"10.1124\/jpet.112.202796_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.112.078154","article-title":"\u03b3-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose","volume":"82","author":"Morse","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.202796_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejps.2012.09.004","article-title":"Activated charcoal for GHB intoxication: an in vitro study","volume":"47","author":"Neijzen","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.112.202796_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00265954","article-title":"Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers","volume":"45","author":"Palatini","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.112.202796_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-013-0973-z","article-title":"Brain extracellular \u03b3-hydroxybutyrate concentrations are decreased by l-lactate in rats: role in the treatment of overdoses","author":"Roiko","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.112.202796_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000542-196503000-00052","article-title":"Oral premedication of children with 4-hydroxybutyrate","volume":"26","author":"Root","year":"1965","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.112.202796_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.106.105965","article-title":"Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters","volume":"318","author":"Wang","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202796_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.107.014852","article-title":"The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202796_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.106.012369","article-title":"Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202796_bib33","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1124\/dmd.108.022996","article-title":"l-lactate and d-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats","volume":"36","author":"Wang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202796_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12248-007-9001-8","article-title":"Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters","volume":"10","author":"Wang","year":"2008","journal-title":"AAPS J"},{"key":"10.1124\/jpet.112.202796_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/dta.292","article-title":"Acute toxicity and withdrawal syndromes related to \u03b3-hydroxybutyrate (GHB) and its analogues \u03b3-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)","volume":"3","author":"Wood","year":"2011","journal-title":"Drug Test Anal"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.202796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:20:30Z","timestamp":1739985630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0022356524185631"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.202796","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Monocarboxylate Transporter Inhibition on the Oral Toxicokinetics\/Toxicodynamics of \u03b3-Hydroxybutyrate and \u03b3-Butyrolactone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.202796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}